J Klassen
Overview
Explore the profile of J Klassen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart D, Guo D, Luider J, Auer I, Klassen J, Morris D, et al.
Hematology
. 2016 Jul;
6(1):19-27.
PMID: 27419600
The purpose of this study was to determine if the CD34+ cell dose is independently associated with progression-free (PFS) and overall survival (OAS) for patients treated with autologous blood stem...
2.
3.
Milgrom F, Klassen J, Fuji H
J Exp Med
. 2009 Oct;
134(3):193-207.
PMID: 19867367
Rejection of renal allografts in man and animals is most frequently induced by cell-mediated immunity, the morphologic hallmark of which is the infiltration of the graft by mononuclear cells. In...
4.
Karlsson L, Quinlan D, Guo D, Brown C, Selinger S, Klassen J, et al.
Bone Marrow Transplant
. 2004 Feb;
33(7):709-13.
PMID: 14755321
This prospective study compared the donor experience of blood cell (BC) mobilization and leukapheresis (n=116) with that of bone marrow (BM) harvest (n=55). Internal jugular catheters were inserted electively in...
5.
Syme R, Stewart D, Rodriguez-Galvez M, Luider J, Auer Y, Klassen J, et al.
Bone Marrow Transplant
. 2003 Jul;
32(3):307-11.
PMID: 12858203
The presence of cancer cells in autografts of breast cancer patients has been described to have prognostic value or directly lead to relapse. Previously, we demonstrated that apheresis products (APs)...
6.
Sasal J, Naimark D, Klassen J, Shea J, Bargman J
Perit Dial Int
. 2001 Oct;
21(4):405-10.
PMID: 11587406
Background: Early renal transplant failure necessitating a return to dialysis has been shown to be a poor prognostic factor for survival. Little is known about the outcome of patients with...
7.
Stewart D, Guo D, Luider J, Auer I, Klassen J, Morris D, et al.
Bone Marrow Transplant
. 2001 Sep;
27(12):1237-43.
PMID: 11548841
Better predictive factors for autologous blood stem cell mobilization (BSCM) are needed. The purpose of this study was to determine if an independent association exists between lymphocyte or NK cell...
8.
Duggan P, Guo D, Luider J, Auer I, Klassen J, Chaudhry A, et al.
Bone Marrow Transplant
. 2001 Feb;
26(12):1299-304.
PMID: 11223969
Data from 170 consecutive patients aged 19-66 years (median age 46 years) who underwent unmanipulated autologous blood stem cell transplant (ASCT) were analyzed to determine if total CD34+ cells/kg infused,...
9.
Stewart D, Guo D, Gluck S, Morris D, Chaudhry A, deMetz C, et al.
Bone Marrow Transplant
. 2000 Sep;
26(4):383-8.
PMID: 10982284
We previously reported a 50% (95% CI = 33-76%) 5 year event-free survival (EFS) rate for 23 patients with Hodgkin's disease (HD) who received salvage therapy with single agent high-dose...
10.
Sadler D, McCarthy M, Saliken J, So C, Klassen J, Selinger S, et al.
J Clin Apher
. 2000 Aug;
15(3):173-5.
PMID: 10962469
Peripheral blood stem cell harvest by apheresis is an increasingly important procedure utilized in the treatment of many malignancies. Whether autologous or allogeneic, it is frequently performed via peripheral access...